Total Visits

Views
CDH22 hypermethylation is an independent prognostic biomarker in breast cancer109

Total Visits Per Month

April 2019May 2019June 2019July 2019August 2019September 2019October 2019
CDH22 hypermethylation is an independent prognostic biomarker in breast cancer0546141522

File Visits

Views
Martin_CDH22.pdf81

Top country views

Views
United States53
China30
Germany12
Spain2
France2
United Kingdom1
Jordan1
Ukraine1
Vietnam1

Top cities views

Views
Fairfield15
Ashburn12
Houston6
Nanjing6
Ann Arbor5
Cambridge4
Ningbo4
Wilmington4
Beijing3
Kunming3